Publications in the literature regarding EPSs produced by thermophilic bacteria and their biological activities are relatively scarce compared to those from mesophilic producers. EPS production levels of some thermophilic bacteria were given as follows; Geobacillus sp. TS3-9, 87 µg/mL [11], G. thermodenitrifcans ArzA-6, 76 µg/mL; G. toebii ArzA-8, 80 µg/mL [27], Geobacillus sp. strain WSUCF1, 404 µg/mL [10], Bacillus licheniformis BITSL006, 45 µg/mL [28], Aeribacillus pallidus 418, 80 µg/mL [14], Geobacillus sp. 4004, 60 µg/mL [5], Parageobacillus thermantarcticus 400 µg/mL [29]. When we examined the EPS production levels (269,7 to 650,9 µg/mL) of the isolates used in our study, we found that they were comparable to those of other thermophilic Gram-positive producers. Considering the total protein content of EPSs, it is calculated to be 0.3%, 1.4%, 1.5%, 0.3%, and 1.2% for EPS20, EPS74, EPS106, EPS111, and EPS206, respectively. Similarly, the EPS produced by G. tepidamans V264 contains 1.8% protein, whereas the EPS produced by thermophilic B. thermoantarcticus has 2% protein [30, 31]. According to Genc et al. the amount of total protein in EPS solution obtained from Anoxybacillus pushchinoensis G11 was determined as 1.08% [32]. Among the EPSs, only EPS111 was thoroughly characterized in our previous publication, which revealed that it consists of hexose (glucose, fructose, galactose, and mannose) and pentose sugars [8]. Comprehensive chemical analyses of the remaining four EPSs are scheduled for future studies. Again, based on the findings of our previous study [8] it was demonstrated that none of the EPSs exhibited cytotoxic effects on blood cells, prompting us to explore the larvicidal and anticancer activities of these metabolites.
Novel strategies to reduce mosquito populations are an urgent priority. Applying EPS to mosquito breeding sites could help mitigate the risks of mosquito-borne diseases. To our knowledge, there are currently no reports regarding the larvicidal activity of EPS derived from members of the Parageobacillus, or Anoxybacillus genera. In a study conducted by Siddharthan et al. the larvicidal bioactivity of Geobacillus thermodenitrificans PS41 was assessed, revealing insecticidal activity against third-instar larvae of Spodoptera litura, which resulted in a mortality rate of 60.26 ± 1.5%. However, the trials utilized extracted secondary metabolites rather than EPS [33].
Our study revealed the larvicidal effects of thermophilic EPSs against Aedes albopictus, a major vector of arboviral diseases such as Chikungunya, dengue fever, and yellow fever. Among the tested bacterial EPSs, 111 and EPS261 were the most effective with LC50 values after 24 hours were 38 µg/mL and 95.5 µg/mL, respectively. The larvicidal activity of EPS obtained from Bacillus licheniformis was tested against the larvae of Anopheles stephensi, a vector for Plasmodium sp. parasites, and Ae. aegypti, which, like Ae. albopictus transmits arboviruses [34]. The LC50 and LC90 values of Bl-EPS against An. stephensi were 61.31 and 127.45 µg/mL, and against Ae. aegypti were 79.28 and 150.68 µg/mL, respectively. These EPS exhibited maximum mortality against both vectors at 150 µg/mL. Similarly, EPS produced by Pseudomonas aeruginosa B01 exhibited potent larvicidal activity against an unspecified mosquito species at a concentration of 10 mg/dL [35].
When evaluating the antitumor effects of the thermophilic EPSs used in this study, purified samples demonstrate a greater inhibitory effect on both healthy and cancerous cells compared to raw EPSs (Table 1). Several in vitro studies have demonstrated that purified polysaccharides are more functional than crude polysaccharides [36, 37]. The anticancer properties of EPSs may result from other unwanted components or impurities present in the samples examined. Therefore, to assert that the activity in the studied material is attributable to EPS, the metabolite must be obtained and utilized in high purity. In our study, the reason pure samples exhibited superior results regarding anticancer activity may stem from the release of specific functional groups, such as sulfate and uronic acid, which can be found in EPSs through purification. Additionally, the varying rates at which thermophilic EPSs exhibit anticancer effects may be attributed to differences in their molecular weights and monosaccharide structures. However, more detailed chemical and structural analyses are required to validate these assertions.
Table 1
Viability percentages of RWPE1 and PC3 cell lines treated with crude and purified EPS at a concentration of 500 mg/mL, along with IC50 values of EPS.
| CRUDE SAMPLES | PURIFIED SAMPLES |
RWPE1 cell line | PC3 cell line | RWPE1 cell line | PC3 cell line |
Cell viability (%) | IC50 value (mg/mL) | Cell viability (%) | IC50 value (mg/mL) | Cell viability (%) | IC50 value (mg/mL) | Cell viability (%) | IC50 value (mg/mL) |
EPS20 | 120 | 2,04 | 92 | 1,28 | 54 | 0,53 | 60 | 0,60 |
EPS74 | 106 | 2,44 | 106 | 1,36 | 67 | 0,67 | 68 | 0,68 |
EPS106 | 116 | 1,76 | 110 | 2,80 | 72 | 0,72 | 45 | 0,45 |
EPS111 | 111 | 3,16 | 112 | 3,24 | 91 | 0,90 | 32 | 0,23 |
EPS261 | 98 | 3,08 | 122 | 2,56 | 97 | 0,97 | 72 | 0,72 |
In our study, the sample exhibiting the most effective anticancer activity against PC3 while maintaining the highest viability of RWPE1 cells is the purified form of EPS111, with an IC50 value of 0.23 mg/mL. It is followed by pure EPS106, which has an LC50 value of 0.45 mg/mL and inhibited PC3 cells by 55%.
It was reported that EPS purified from Bacillus licheniformis AG-06, exhibited significant cytotoxic activity (IC50 value of 37.5 ± 0.87 µg/mL) against human lung carcinoma cells (A549) and thus demonstrates strong anticancer potential [38]. In another study, it was found that crude EPS derived from Anoxybacillus pushchinoensis G11 showed a cytotoxic effect on A-549 and colon cancer (Caco-2 and HT-29) cell lines at a concentration of 2.5 mg/mL [32]. Wang et al. evaluated the antitumor activity of purified samples of EPS from Geobacillus sp. TS3-9 strain on hepatoma carcinoma cells (HepG2) using MTT analysis. The inhibitory effect of EPS on the proliferation of HepG2 was dose-dependent at concentrations ranging from 4 µg/mL to 100 µg/mL, with the inhibition rate varying from 2.2–16.9%, respectively [11]. Two exopolysaccharides (EPS-1 and EPS-2) purified from the Geobacillus sp. WSUCF1 strain exhibited no cytotoxicity against human embryonic kidney-293 (HEK-293) cells at concentrations of 2 and 3 mg/mL, respectively [10]. Arena et al. revealed that exopolysaccharide (EPS-2) produced by G. thermodenitrificans B3-72 strain inhibited HSV-2 replication in human peripheral blood mononuclear cells (PBMC), but not in WISH cells [7].